The two major PUFAs that cause ferroptosis are arachidonic acid (AA) and adrenic acid (AdA) [26]
Existing studies also differ substantially in population, drug type, dose, treatment duration, follow-up window, endpoint definition, and control of gastrointestinal symptoms or other state-related confounders
doi: 10.17925/EE.2022.18.1.10
M., Sun, J., Sharma, L., & Libin, J
Las personas con obesidad suelen presentar baja calidad muscular y una disminucin de la capacidad cardiorrespiratoria , un factor que predice de manera independiente la mortalidad total y cardiovascular
Useful tracking points include: Baseline eye exam status Existing AMD diagnosis or family history Diabetes status and HbA1c trend Blood pressure and lipid markers Smoking history GLP-1 medication, dose, and start date Speed of weight loss New visual symptoms, distortion, blurred central vision, floaters, or dark spots Ophthalmology follow-up dates and findings PeptIQ is not a replacement for an eye exam